Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew H Karaba

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Pediatric Research|September 9, 2014
Herpes simplex virus serotype and entry receptor availability alter CNS disease in a mouse model of neonatal HSVSarah J Kopp, Hantamalala R Ranaivo, Douglas R Wilcox, et al.
Mbio|January 10, 2023
Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 TreatmentAndrew H Karaba, Trevor S Johnston, Evan Beck, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2022
Discordant Antibody and T-Cell Responses to the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in Coronavirus Disease 2019 Messenger RNA Vaccine RecipientsBezawit A Woldemeskel, Caroline C Garliss, Tihitina Y Aytenfisu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2021
The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living With Human Immunodeficiency Virus (HIV)Bezawit A Woldemeskel, Andrew H Karaba, Caroline C Garliss, et al.
Journal of the Pediatric Infectious Diseases Society|May 21, 2013
Longitudinal Characterization of Herpes Simplex Virus (HSV) Isolates Acquired From Different Sites in an Immune-Compromised Child: A New HSV Thymidine Kinase Mutation Associated With ResistanceAndrew H Karaba, Laura K Cohen, Taly Glaubach, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 3, 2021
Interleukin-18 and tumor necrosis factor-α are elevated in solid organ transplant recipients with possible cytomegalovirus end-organ diseaseAndrew H Karaba, Alexis Figueroa, William A Werbel, et al.
Open Forum Infectious Diseases|December 26, 2022
Disseminated Tuberculosis With an Atypical Cutaneous Manifestation in a Hematopoietic Cell Transplant Patient in the Early Posttransplant Period: Case Report and Review of the LiteratureMary M Czech, Maria Veronica Dioverti, Andrew H Karaba, et al.
AIDS (London, England)|July 14, 2021
Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIVJake A Ruddy, Brian J Boyarsky, Justin R Bailey, et al.
AIDS (London, England)|May 16, 2021
Safety and antibody response to the first dose of severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine in persons with HIVJake A Ruddy, Brian J Boyarsky, William A Werbel, et al.
Kidney International Reports|February 24, 2025
Longitudinal Characterization of SARS-CoV-2 Immunity in Hemodialysis Patients Post OmicronAndrew H Karaba, Jiashu Xue, Trevor S Johnston, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Pediatric Research|September 9, 2014
Herpes simplex virus serotype and entry receptor availability alter CNS disease in a mouse model of neonatal HSVSarah J Kopp, Hantamalala R Ranaivo, Douglas R Wilcox, et al.
Mbio|January 10, 2023
Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 TreatmentAndrew H Karaba, Trevor S Johnston, Evan Beck, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2022
Discordant Antibody and T-Cell Responses to the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in Coronavirus Disease 2019 Messenger RNA Vaccine RecipientsBezawit A Woldemeskel, Caroline C Garliss, Tihitina Y Aytenfisu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2021
The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living With Human Immunodeficiency Virus (HIV)Bezawit A Woldemeskel, Andrew H Karaba, Caroline C Garliss, et al.
Journal of the Pediatric Infectious Diseases Society|May 21, 2013
Longitudinal Characterization of Herpes Simplex Virus (HSV) Isolates Acquired From Different Sites in an Immune-Compromised Child: A New HSV Thymidine Kinase Mutation Associated With ResistanceAndrew H Karaba, Laura K Cohen, Taly Glaubach, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 3, 2021
Interleukin-18 and tumor necrosis factor-α are elevated in solid organ transplant recipients with possible cytomegalovirus end-organ diseaseAndrew H Karaba, Alexis Figueroa, William A Werbel, et al.
Open Forum Infectious Diseases|December 26, 2022
Disseminated Tuberculosis With an Atypical Cutaneous Manifestation in a Hematopoietic Cell Transplant Patient in the Early Posttransplant Period: Case Report and Review of the LiteratureMary M Czech, Maria Veronica Dioverti, Andrew H Karaba, et al.
AIDS (London, England)|July 14, 2021
Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIVJake A Ruddy, Brian J Boyarsky, Justin R Bailey, et al.
AIDS (London, England)|May 16, 2021
Safety and antibody response to the first dose of severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine in persons with HIVJake A Ruddy, Brian J Boyarsky, William A Werbel, et al.
Kidney International Reports|February 24, 2025
Longitudinal Characterization of SARS-CoV-2 Immunity in Hemodialysis Patients Post OmicronAndrew H Karaba, Jiashu Xue, Trevor S Johnston, et al.
Pageof 6